This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Did this page help you?
Tell us in one minuteRelated information
A rare case of aspergillosis reported after compost exposure
September 25, 2026
A patient describes his life with chronic pulmonary aspergillosis
September 25, 2026
RW: living with CPA and long-term antifungal treatment
September 25, 2026
MD: living with CPA, aspergilloma and antifungal resistance
September 25, 2026

